Osborne Clarke advised Creo Medical Group Plc on the deal. Creo Medical Group PLC, an AIM-quoted medical devices company focusing on the emerging field of surgical...
You must be a Standard 1 Year member to access this content.
Osborne Clarke has advised Wilmington Plc on the deal. Wilmington plc, the UK listed provider of data, information, education and training in the global Governance, Risk...
You must be a Standard 1 Year member to access this content.
On the deal, Linklaters acted for HG while Osborne Clarke advised Focus Group. Hg, a leading investor in European and transatlantic software and services businesses, completed...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Singer Capital Markets, in its capacity as nominated adviser on TheWorks.co.uk plc’s move to AIM from the Main Market. The Works is one...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Wilmington plc on its acquisition. Wilmington plc, the provider of data, information, education and training services in the global Governance, Risk and Compliance markets,...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advised Singer Capital Markets on Chapel Down’s admission to AIM. Singer Capital Markets, acted as nominated adviser on Chapel Down Group plc’s move to AIM...
You must be a Standard 1 Year member to access this content.
Osborne Clarke advises a consortium made up of Berry Bros. & Rudd and Symington Family Estates on the deal. CVI UK Ltd, a company formed at...
You must be a Standard 1 Year member to access this content.
